|
1
|
The impact of blood transfusion on morbidity and mortality after cardiac surgery.
|
Rev Bras Cir Cardiovasc
|
2011
|
1.03
|
|
2
|
A score proposal to evaluate surgical risk in patients submitted to myocardial revascularization surgery.
|
Rev Bras Cir Cardiovasc
|
2011
|
0.90
|
|
3
|
Risk score elaboration for mediastinitis after coronary artery bypass grafting.
|
Rev Bras Cir Cardiovasc
|
2010
|
0.88
|
|
4
|
Atrioventricular block in the postoperative period of heart valve surgery: incidence, risk factors and hospital evolution.
|
Rev Bras Cir Cardiovasc
|
2011
|
0.80
|
|
5
|
The use of inhibitors of angiotensin-converting enzyme and its relation to events in the postoperative period of CABG.
|
Rev Bras Cir Cardiovasc
|
2011
|
0.76
|
|
6
|
Risk scores in heart valve surgery.
|
Arq Bras Cardiol
|
2013
|
0.75
|
|
7
|
Preoperative serum fibrinogen as a predictor of myocardial infarction in the surgical myocardial revascularization.
|
Arq Bras Cardiol
|
2006
|
0.75
|